Skip to main content
Professional Technical IVT

Duchenne muscular dystrophy

Pronunciation: doo-SHEN muscular dystrophy

X-linked recessive muscular dystrophy caused by dystrophin gene mutations, characterized by progressive muscle weakness beginning in early childhood.

Full Definition

Duchenne muscular dystrophy (DMD) is the most common and severe form of muscular dystrophy, caused by mutations in the dystrophin gene on the X chromosome. The condition primarily affects boys, with onset typically between ages 2-5 years, presenting as delayed motor milestones, proximal muscle weakness, and pseudohypertrophy of calves. Progressive muscle degeneration leads to loss of ambulation by adolescence, followed by respiratory and cardiac complications. Diagnosis involves elevated creatine kinase levels, muscle biopsy showing dystrophin absence, and genetic testing. Treatment focuses on corticosteroids, physical therapy, and multidisciplinary supportive care.

Usage

Usage note: Capitalize 'Duchenne' as it is an eponym; DMD abbreviation is acceptable in clinical contexts.

In Context

  • "Genetic counseling is essential for families affected by Duchenne muscular dystrophy due to its X-linked inheritance pattern." — Patient education material
  • "The boy's Duchenne muscular dystrophy was diagnosed following markedly elevated CK levels and positive genetic testing." — Medical case study

Also known as

DMD

Don't confuse with

Becker muscular dystrophy limb-girdle muscular dystrophy

Editors from these organisations have used our services since 1998

Reuters BBC Oxford University Press Penguin Random House Springer Microsoft Suncor Energy United Nations Fisher Investments IBM The Home Depot KODAK CHEVRON